154 related articles for article (PubMed ID: 9723252)
1. Cyclosporine: the principal immunosuppressant for renal transplantation.
Keown PA; Primmett DR
Transplant Proc; 1998 Aug; 30(5):1712-5. PubMed ID: 9723252
[No Abstract] [Full Text] [Related]
2. Reduced acute rejection after liver transplantation with Neoral-based double immunosuppression.
Reggiani P; Rossi G; Latham L; Caccamo L; Gatti S; Maggi U; Melada E; Paone G; Doglia M; Vannelli A; Fassati LR
Transplant Proc; 1998 Aug; 30(5):1855-6. PubMed ID: 9723308
[No Abstract] [Full Text] [Related]
3. Safety and effectiveness of microemulsion cyclosporine in renal allograft recipients: 1-year follow-up study.
Park K; Kim MS; Kim SI; Kim YS; Moon JI
Transplant Proc; 1998 Nov; 30(7):3556-7. PubMed ID: 9838557
[No Abstract] [Full Text] [Related]
4. Neoral versus Sandimmune in kidney transplantation.
Tisone G; Orlando G; Mercadante E; Vennarecci G; Pisani F; Buonomo O; Negrini S; Casciani CU
Transplant Proc; 1998 Aug; 30(5):1749-50. PubMed ID: 9723265
[No Abstract] [Full Text] [Related]
5. Effect of tacrolimus on the outcome of renal transplantation with donor-specific blood transfusion.
Miura S; Okazaki H; Sato T; Amada N; Ohashi Y
Transplant Proc; 1998 Jun; 30(4):1212-3. PubMed ID: 9636492
[No Abstract] [Full Text] [Related]
6. Preoperative induction therapy with oral cyclosporine for recipients of living-related renal transplants.
Rudich SM; Bhaduri S; Chang T; Cahn J; Katznelson S; Perez RV
Transplant Proc; 1998 Jun; 30(4):1339-42. PubMed ID: 9636545
[No Abstract] [Full Text] [Related]
7. Pregnancy outcomes in female renal transplant recipients.
Armenti VT; McGrory CH; Cater JR; Radomski JS; Moritz MJ
Transplant Proc; 1998 Aug; 30(5):1732-4. PubMed ID: 9723259
[No Abstract] [Full Text] [Related]
8. Reduced acute rejection after liver transplantation with Neoral-based triple immunosuppression.
Mirza DF; Gunson BK; Soonawalla Z; Pirenne J; Mayer AD; Buckels JA; McMaster P
Lancet; 1997 Mar; 349(9053):701-2. PubMed ID: 9078209
[No Abstract] [Full Text] [Related]
9. Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation.
Bruce DS; Woodle ES; Newell KA; Millis JM; Cronin DC; Loss GE; Grewal HP; Siegel CT; Pellar S; Josephson MA; Thistlethwaite JR
Transplant Proc; 1998 Jun; 30(4):1538-40. PubMed ID: 9636625
[No Abstract] [Full Text] [Related]
10. A critical appraisal of cyclosporine A pharmacokinetics in pediatric kidney transplantation using a microemulsion galenic formulation (Neoral).
Foradori A; Pinto VM; Elberg A
Transplant Proc; 1998 Aug; 30(5):1666-7. PubMed ID: 9723235
[No Abstract] [Full Text] [Related]
11. Neoral reduces the incidence of acute rejection after renal transplantation.
Sandrini S; Setti G; Gaggia P; Chiappini R; Maffeis R; Tardanico R; Maiorca R
Transplant Proc; 1998 Aug; 30(5):1758-9. PubMed ID: 9723269
[No Abstract] [Full Text] [Related]
12. Improvement of correlation between oral dose of cyclosporine and cyclosporinemia after substitution of cyclosporine standard presentation by cyclosporine microemulsion one, in 1345 patients with kidney transplantation. Spanish Sandimmune Neoral Conversion Group.
Gentil Govantes MA; Gómez Ullate P; Errasti P; Fernández Fresnedo G; Capdevila L; Sanz Guajardo A; Cubero JJ
Transplant Proc; 1998 Aug; 30(5):1658-9. PubMed ID: 9723231
[No Abstract] [Full Text] [Related]
13. Use of microemulsion form cyclosporine immediately after kidney transplantation without intravenous cyclosporine.
Jirasiritham S; Sumethkul V; Mavichak V; Jirasiritham S
Transplant Proc; 1998 Aug; 30(5):1760-1. PubMed ID: 9723270
[No Abstract] [Full Text] [Related]
14. Acute allograft rejection following conversion to a new cyclosporine formulation in pediatric renal transplant patients.
Crocker J; Renton K; Wade A; McLellan H; Acott P
Transplant Proc; 1998 Aug; 30(5):2002-5. PubMed ID: 9723369
[No Abstract] [Full Text] [Related]
15. Therapeutic approach with patient-specific cyclosporine administration protocol in renal transplantation.
Sernyak PS; Chernobrivtsev PA; Kalinin DI; Lunyova AG; Denisov VK
Transplant Proc; 1997; 29(1-2):296. PubMed ID: 9123003
[No Abstract] [Full Text] [Related]
16. Low exposure to cyclosporine is a risk factor for the occurrence of chronic rejection after kidney transplantation.
Citterio F; Torricelli P; Serino F; Foco M; Pozzetto U; Fioravanti P; Castagneto M
Transplant Proc; 1998 Aug; 30(5):1688-90. PubMed ID: 9723245
[No Abstract] [Full Text] [Related]
17. Optimization of cyclosporine therapy in renal transplantation.
Ponticelli C
Transplant Proc; 1998 Aug; 30(5):1718-20. PubMed ID: 9723254
[No Abstract] [Full Text] [Related]
18. Verapamil improves Sandimmune immunosuppression, reducing acute rejection episodes.
Citterio F; Serino F; Pozzetto U; Fioravanti P; Caizzi P; Castagneto M
Transplant Proc; 1996 Aug; 28(4):2174-6. PubMed ID: 8769192
[No Abstract] [Full Text] [Related]
19. Withdrawal of steroids from a cyclosporine-based regimen: pro.
Ponticelli C
Transplant Proc; 1998 Aug; 30(5):1782-4. PubMed ID: 9723281
[No Abstract] [Full Text] [Related]
20. A meta-analysis to assess the safety and tolerability of two formulations of cyclosporine: Sandimmune and Neoral.
Shah MB; Martin JE; Schroeder TJ; First MR
Transplant Proc; 1998 Dec; 30(8):4048-53. PubMed ID: 9865291
[No Abstract] [Full Text] [Related]
[Next] [New Search]
